Role of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Systematic Review and Updated Meta-Analysis of Risk Markers for Sudden Death

Abstract

BackgroundHypertrophic cardiomyopathy (HCM) is associated with sudden death (SD). Myocardial fibrosis is reportedly correlated with SD.ObjectiveWe performed a systematic review with meta-analysis, updating the risk markers (RMs) in HCM emphasizing myocardial fibrosis.MethodsWe reviewed HCM studies that addressed severe arrhythmic outcomes and the certain RMs: SD family history, severe ventricular hypertrophy, unexplained syncope, non-sustained ventricular tachycardia (NSVT) on 24-hour Holter monitoring, abnormal blood pressure response to exercise (ABPRE), myocardial fibrosis and left ventricular outflow tract obstruction (LVOTO) in the MEDLINE, LILACS, and SciELO databases. We used relative risks (RRs) as an effect measure and random models for the analysis. The level of significance was set at p < 0.05.ResultsTwenty-one studies were selected (14,901 patients aged 45 ± 16 years; men, 62.8%). Myocardial fibrosis was the major RISK MARKER (RR, 3.43; 95% CI, 1.95-6.03). The other RMs, except for LVOTO, were also predictors: SD family history (RR, 1.75; 95% CI, 1.39-2.20), severe ventricular hypertrophy (RR, 1.86; 95% CI, 1.26-2.74), unexplained syncope (RR, 2.27; 95% CI, 1.69-3.07), NSVT (RR, 2.79; 95% CI, 2.29-3.41), and ABPRE (RR, 1.53; 95% CI, 1.12-2.08).ConclusionsWe confirmed the association of myocardial fibrosis and other RMs with severe arrhythmic outcomes in HCM and emphasize the need for new prediction models in managing these patients.

YBX-1 mediated sorting of miR-133 into hypoxia/reoxygenation-induced EPC-derived exosomes to increase fibroblast angiogenesis and MEndoT

“…Myocardial fibrosis is a common pathophysiological change in cardiovascular disease, which can cause cardiac dysfunction and even sudden death [1]. It is one of the important causes of death in patients with cardiovascular disease.…”

Global research trends of hypertrophic cardiomyopathy from 2000 to 2022: Insights from bibliometric analysis

“…Myocardial fibrosis is a common pathological state in HCM and various other cardiac diseases and is an essential cause of ventricular tachyarrhythmia caused by reentrant activity and initiation trigger mechanisms ( 22 ). Multiple clinical studies and meta-analyses have shown that ventricular fibrosis detected using LGE is a powerful predictor of sudden cardiac death (SCD) events in patients with HCM ( 21 , 23 – 26 ). The advanced cardiac imaging functional assessment combined with the SCD risk prediction model based on traditional clinical parameters ( 9 ) provides individualized assessment for the risk stratification of the HCM population including SCD events risk.…”

Imaging Targets to Visualize the Cardiac Immune Landscape in Heart Failure

“…Patients with HFpEF experience low-grade systemic and local inflammation. 72,73 Cardiac macrophage abundance is increased in HFpEF models. 74 These hearts display increased populations of infiltrating monocytes and macrophages, specifically CXCR4 + monocytes and CCR2 + macrophages, and decreased abundance of cardiac tissue-resident macrophages.…”